Product Information

TOBRAMYCIN 80 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.9279 per ML under NDC 00409357801. Its NADAC has been published 321 times since Nov 28, 2013.

FDA first approved this application on Apr 30, 1991. Its Orange Book therapeutic-equivalence code is AP.

The Low Outlier badge above means this manufacturer's average price in the TOBRAMYCIN market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TOBRAMYCIN 80 MG/2 ML VIAL

TOBRAMYCIN
$0.9279per ML
Low Outlier

Strength

40 mg/mL

Manufacturer

Hospira Inc.

NDC

00409357801

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

10/21/2026

Active Ingredients

TOBRAMYCIN SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA063111

FDA Approved

4/30/1991

TE Code

AP

On Market Since

5/5/2005

Pharmacological Classes

Price Statistics

The NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has been published 321 times since Nov 28, 2013, and over the history we have for it it has declined 27.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9279 per ML
All-time high$1.4932 (Jan 15, 2014)
All-time low$0.5997 (Mar 18, 2026)
52-week high$0.9279
52-week low$0.5997
Median price$0.8443
Average price$0.8459
Largest weekly change+101.1% (Aug 20, 2014)
Weeks tracked321
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+11.6%

3M

+42.7%

6M

+47.4%

1Y

+14.3%

3Y

+9.2%

5Y

+9.2%

All

-27.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TOBRAMYCIN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOBRAMYCIN 80 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 80 MG/2 ML VIAL, manufactured by Hospira Inc., is $0.9279 per ML (NDC 00409357801), effective Nov 11, 2026.

How has the price of TOBRAMYCIN 80 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has declined 27.3%. It has been tracked across 321 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 80 MG/2 ML VIAL?

Since Nov 28, 2013, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has ranged from a low of $0.5997 (Mar 18, 2026) to a high of $1.4932 (Jan 15, 2014), with a median of $0.8443 per ML.

Are there cheaper alternatives to TOBRAMYCIN 80 MG/2 ML VIAL?

No other NADAC-published product currently shares the active ingredient and strength of TOBRAMYCIN 80 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TOBRAMYCIN 80 MG/2 ML VIAL?

TOBRAMYCIN 80 MG/2 ML VIAL (NDC 00409357801) is labeled by Hospira Inc., and CMS classifies it as a generic product.